Johns Hopkins Diabetes Guide →Complications and Comorbidities →Endocrine

Somatostatinoma

Amin Sabet, M.D., Reshmi Srinath, M.D.
Somatostatinoma is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

DEFINITION

  • Rare somatostatin-producing neuroendocrine tumors (NETs) which arise primarily in the pancreas (from D cells) and duodenum
  • May or may not secrete excess somatostatin, called somatostatin syndrome.
  • Somatostatin inhibits the secretion of endocrine hormones including insulin which contributes to diabetes as well as paracrine hormones including cholecystokinin, VIP, GIP, PP[11]

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 26, 2015

Citation

TY - ELEC T1 - Somatostatinoma ID - 547136 A1 - Sabet,Amin,M.D. AU - Srinath,Reshmi,M.D. Y1 - 2015/02/26/ PB - Johns Hopkins Diabetes Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_Diabetes_Guide/547136/all/Somatostatinoma ER -